News

Alto Neuroscience Starts IPO Plan For CNS Disorder Treatments (Pending:ANRO)

4 Mins read

A Quick Take On Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (ANRO) has filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.

The firm is a

Read the full article here

Related posts
News

Supercharge SCHD ETF With Big Dividend Machines

1 Mins read
This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several…
News

KB Home (KBH) Q2 2025 Earnings Call Transcript

1 Mins read
KB Home (NYSE:KBH) Q2 2025 Earnings Conference Call June 23, 2025 5:00 PM ET Company Participants Jeffrey T. Mezger – Chairman &…
News

Advance Auto Parts Stock: Rally Is Not Supported By Fundamentals (NYSE:AAP)

1 Mins read
This article was written by Follow Over fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *